USANA Health Sciences, Inc. Forecasted to Earn FY2024 Earnings of $2.75 Per Share (NYSE:USNA)

USANA Health Sciences, Inc. (NYSE:USNA) – Equities researchers at DA Davidson upped their FY2024 earnings per share estimates for shares of USANA Health Sciences in a research note issued to investors on Tuesday, May 7th. DA Davidson analyst L. Weiser now expects that the company will post earnings of $2.75 per share for the year, up from their previous estimate of $2.70. DA Davidson has a “Neutral” rating and a $46.00 price objective on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.75 per share. DA Davidson also issued estimates for USANA Health Sciences’ FY2025 earnings at $2.90 EPS.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. The business had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th.

USANA Health Sciences Trading Up 2.9 %

Shares of USNA stock opened at $46.32 on Thursday. The firm’s fifty day moving average price is $46.38 and its two-hundred day moving average price is $48.04. USANA Health Sciences has a 1 year low of $41.45 and a 1 year high of $69.60. The firm has a market capitalization of $889.34 million, a P/E ratio of 14.43, a PEG ratio of 1.38 and a beta of 0.94.

Institutional Investors Weigh In On USANA Health Sciences

Hedge funds have recently made changes to their positions in the stock. CWM LLC increased its position in USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock valued at $75,000 after acquiring an additional 276 shares during the period. New York State Common Retirement Fund increased its holdings in USANA Health Sciences by 1.2% in the fourth quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock valued at $1,313,000 after purchasing an additional 279 shares during the period. Swiss National Bank raised its position in USANA Health Sciences by 1.2% during the 3rd quarter. Swiss National Bank now owns 25,500 shares of the company’s stock worth $1,495,000 after purchasing an additional 300 shares during the last quarter. Rhumbline Advisers raised its position in USANA Health Sciences by 1.4% during the 3rd quarter. Rhumbline Advisers now owns 34,942 shares of the company’s stock worth $2,048,000 after purchasing an additional 496 shares during the last quarter. Finally, Strs Ohio lifted its holdings in USANA Health Sciences by 4.8% during the 3rd quarter. Strs Ohio now owns 10,900 shares of the company’s stock worth $638,000 after buying an additional 500 shares during the period. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other USANA Health Sciences news, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total transaction of $232,662.48. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The disclosure for this sale can be found here. Insiders have sold 34,286 shares of company stock valued at $1,634,010 in the last 90 days. 0.33% of the stock is currently owned by insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.